12 Atopic Dermatitis Clinical Trials in Fountain Valley, CA (2026)

Q: How do I join a clinical trial in Fountain Valley?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you.

Recruiting Atopic Dermatitis Studies in Fountain Valley

NCT06129864Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HN...

Fountain Valley, CAPHASE31,145 participantsAstraZeneca

View Study Details

NCT06988605Recruiting

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at ...

Fountain Valley, CA1,000 participantsGalderma R&D

View Study Details

NCT06855498Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib....

Fountain Valley, CAPHASE3600 participantsIncyte Corporation

View Study Details

NCT06380751Recruiting

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

The primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2, or PALB2m, HR-positiv...

Fountain Valley, CAPHASE3500 participantsAstraZeneca

View Study Details

NCT05932862Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and pharmacodynamics of ...

Fountain Valley, CAPHASE1429 participantsExelixis

View Study Details

NCT07003425Recruiting

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an A...

Fountain Valley, CAPHASE2350 participantsApogee Therapeutics, Inc.

View Study Details

NCT07228390Recruiting

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

The purpose of this study is to learn about the safety and effects of the study medicine (called Ritlecitinib) for the possible treatment of hidradenitis suppurativa (HS). HS is a disease causing long...

Fountain Valley, CAPHASE2240 participantsPfizer

View Study Details

NCT06947993Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD)....

Fountain Valley, CAPHASE2224 participantsNovartis Pharmaceuticals

View Study Details

NCT06389136Recruiting

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants w...

Fountain Valley, CAPHASE3200 participantsAbbVie

View Study Details

NCT07230860Recruiting

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD)....

Fountain Valley, CAPHASE2180 participantsJanssen Research & Development, LLC

View Study Details

NCT06397911Recruiting

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic de...

Fountain Valley, CAPHASE2114 participantsOneness Biotech Co., Ltd.

View Study Details

NCT07244263Recruiting

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) is a skin condition that causes deep, painful bumps on the skin. These bumps usually appear in an area where the skin rubs together. They start as small bumps but may bec...

Fountain Valley, CAPHASE290 participantsTakeda

View Study Details

About Atopic Dermatitis Clinical Trials in Fountain Valley

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 12 atopic dermatitis clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 5,072 participants. Research is being sponsored by AstraZeneca, Galderma R&D, Incyte Corporation and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Fountain Valley — FAQ

Are there atopic dermatitis clinical trials in Fountain Valley?

Yes, there are 12 atopic dermatitis clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fountain Valley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.

Are clinical trials in Fountain Valley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 12 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 17, 2026 from ClinicalTrials.gov